• Science and Research

  Inhaled Form of Teicoplanin for CF Patients Goal of Italfarmaco, Neupharma Partnernership

  Posted by Cystic Fibrosis News Moderator on August 12, 2019 at 7:45 pm

  Italfarmaco and Neupharma plan to develop an inhaled formulation of the antibiotic teicoplanin to treat resistant, Gram-positive bacteria like MRSA. Read more about it.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 6 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply